BFSG LLC’s Global Blood Therapeutics, Inc. GBT Stock Holding History

BFSG LLC’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,342	Closed	-$527K	–	198
2020 Q2	$527K	Buy	+8,342	New	+$572K	0.11%	136

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFSG LLC's GBT Position: Q3 2020 in Review

BFSG LLC sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 8,342 shares — an estimated $527K sold.

BFSG LLC first reported a position in GBT in Q2 2020 and held it in 1 quarter. The position peaked at $527K in Q2 2020. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

BFSG LLC reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
BFSG LLC sold 8,342 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $527K.
BFSG LLC first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
BFSG LLC's Global Blood Therapeutics, Inc. position peaked at $527K in Q2 2020.
229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on BFSG LLC's 13F filing for Q3 2020, filed 4 Nov 2020.